Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2019

Open Access 01.12.2019 | Research article

The use of data science to analyse physiology of oxygen delivery in the extracorporeal circulation

verfasst von: Marceli Lukaszewski, Rafal Lukaszewski, Kinga Kosiorowska, Marek Jasinski

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2019

Abstract

Background

Recent scientific reports have brought into light a new concept of goal-directed perfusion (GDP) that aims to recreate physiological conditions in which the risk of end-organ malperfusion is minimalized. The aim of our study was to analyse patients’ interim physiology while on cardiopulmonary bypass based on the haemodynamic and tissue oxygen delivery measurements. We also aimed to create a universal formula that may help in further implementation of the GDP concept.

Methods

We retrospectively analysed patients operated on at the Wroclaw University Hospital between June 2017 and December 2018. Since our observations provided an extensive amount of data, including the patients’ demographics, surgery details and the perfusion-related data, the Data Science methodology was applied.

Results

A total of 272 (mean age 62.5 ± 12.4, 74% male) cardiac surgery patients were included in the study. To study the relationship between haemodynamic and tissue oxygen parameters, the data for three different values of DO2i (280 ml/min/m2, 330 ml/min/m2 and 380 ml/min/m2), were evaluated. Each set of those lines showed a descending function of CI in Hb concentration for the set DO2i.

Conclusions

Modern calculation tools make it possible to create a common data platform from a very large database. Using that methodology we created models of haemodynamic compounds describing tissue oxygen delivery. The obtained unique patterns may both allow the adaptation of the flow in relation to the patient’s unique morphology that changes in time and contribute to wider and safer implementation of perfusion strategy which has been tailored to every patient’s individual needs.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CABG
Coronary artery bypass grafting
CI
Cardiac index
CPB
Cardiopulmonary bypass
DO2
Oxygen delivery
DO2i
Oxygen delivery indexed to Body Surface Area
EBM
Evidence-based medicine
ec
extracorporeal
ECC
Extracorporeal circulation
GDP
Goal-directed perfusion
Hb
Haemoglobin
MAP
Mean arterial pressure
O2ER
Ratio of oxygen consumed to oxygen delivered
SVO2
Mixed venous oxygen saturation
VCO2
Carbon dioxide production
VO2
Oxygen consumption

Background

The emergence of extracorporeal circulation (ECC) has been a milestone in the history of heart surgery. Throughout the years, the ECC procedure of commencing the heart-lung machine and switching off the heart together with a pulmonary circulation from the bloodstream has been the gold standard of the majority of cardiac surgery procedures. Nonetheless, the ECC procedure is associated with significant postoperative complications, occurring either de novo or as an exacerbation of existing organ dysfunctions. It may also influence the coagulation system and trigger the vasoplegic syndrome [1]. Recently, much attention has been devoted to the detrimental effects of inadequate organ perfusion on cardiopulmonary bypass (CPB) [2]. The current widely accepted CPB management strategies are based on simplified schemes including regulation of core perfusion parameters, thus not restoring the patient’s unique physiological circulation. The pump flow rate usually remains constant and is set on 2.2–2.4 l/min/m2 [3]. The perfusion pressure that optimizes transmembrane transport is maintained above 50 mmHg, which is the lowest value of cerebral blood flow autoregulation [4]. The problem of ECC management is aggravated by the lack of EBM-based standards covering basic haemodynamic parameters, i.e., pump flow rate and perfusion pressure, as well as haemodilution range or indications for the vasoconstrictors use. This has led clinicians to adapt different ranges of defined core parameters for guiding the perfusion throughout cardiac surgical units worldwide [1, 2, 4].
A haemodynamic patient – heart-lung machine model aims to study the disparity between the patient’s unique haemodynamics during the ECC procedure and CPB settings. Currently applicable perfusion protocols are based solely on physiological haemodynamic parameters, such as CI or perfusion pressure. Consequently, they apply the same average parameters to each patient, which does not seem adequate since the initiation of the heart-lung machine changes the physiological haemodynamic conditions. Therefore, the implementation of non-invasive real-time monitoring of oxygen transport and haemodynamics has become an intrinsic factor for the newly introduced concept, the so-called Goal-Directed Perfusion (GDP). The aim of this concept is to restore the physiological conditions of cell and tissue respiration during the ECC by optimizing both tissue oxygen delivery and extraction. The evidence proving the effectiveness of this concept is very limited, with only a handful of articles demonstrating favourable clinical impact on the reduction of CPB-related complications, such as kidney or CNS injury. The oxygen supply threshold (DO2), below which the deterioration of end-organ function can be observed, was set above 272 ml/m2/min [5, 6]. Additionally, new parameters determining adequate oxygen transport, such as percentage oxygen saturation of venous blood (SvO2), oxygen consumption (VO2), ratio of oxygen consumed to oxygen delivered (O2ER) and oxygen delivery indexed to body surface area to carbon dioxide production indexed to body surface area ratio (DO2i/VCO2i) were adopted. Yet the DO2i/VCO2i ratio often remains blurred due to frequent CO2 insufflations into the operating field for the anti-embolic purposes.
$$ {\mathrm{DO}}_2=\mathrm{pump}\ \mathrm{flow}\ \mathrm{x}\ \left[\left(\mathrm{Hg}\ \mathrm{x}\ \mathrm{Sat}\ \mathrm{x}\ 1,36\right)+\left(0.003\ \mathrm{x}\ \mathrm{PaO}2\right)\right] $$
DO2 is directly proportional to the oxygen content in the blood and, therefore, the pump flow rate enables the adjustment of these two parameters to obtain satisfactory DO2 value. Perfusion pressure depends on the cardiac output and the vascular tone, whereas on CPB it depends mainly on the flow rate and blood viscosity. Systemic vascular resistance, as usually practiced, can be modified through vasoactive agents [7].
The aim of our observational study was to find physiological relationships between the patient’s haemodynamics and the heart-lung machine settings that would then allow to introduce the perfusion tailored to the individual patient’s needs and to spread the concept around the world.

Methods

We performed a retrospective analysis of 272 consecutive cardiac surgery patients operated on at the Wroclaw University Hospital between June 2017 and December 2018. Each procedure was conducted with the use of the S5 Heart-Lung Machine (LivaNova PLC, London, UK) equipped with the System M real-time non-invasive monitoring (Spectrum Medical, Gloucester, UK). All the procedures were carried out according to the ward standards in normothermia. The patients’ agreement for treatment and data collection was approved by the local Bioethics Committee.

Data collection and statistical analysis

The dataset of 272 cases, which amounts to over 351 thousand rows of data, was collected from both electronic medical records and the VIPER data management system, where all the perfusion-related data were collected. Demographic data were expressed as mean values with either a standard deviation (SD) for continuous variable data or as a percentage of the total for categorical data (Table 1). We compared: patient baseline characteristics with operative details obtained from electronic medical records, results of sensors in-line monitoring and pump flow rate measurements. An enormous amount of data and the diversity of the data pattern determined the use the Data Science calculation tools [8]. According to Data Science nomenclature, our estimates are described as: structured data (e.g., laboratory results), semi-structured data (e.g., sensor data) and unstructured data (e.g., patient notes) [911]. Additionally, using the Data Science capabilities we looked for adequate pump flow rates for which relevant GDP conditions, such as DO2 > 280 ml/m2/min, SvO2 > 68% and MAP> 60 mmHg, were met. Our toolset was based in on Anaconda Distribution (Anaconda Inc., https://​www.​anaconda.​com), Python 3.6 (Python Software Foundation, https://​www.​python.​org) and Jupyter Notebook (Jupyter Project, https://​jupyter.​org). Data cleaning and analysis was performed using Pandas (Python Data Analysis Library), whereas visualization was done with Matplotlib (Matplotlib Development Team, https://​matplotlib.​org) and Seaborn libraries (https://​seaborn.​pydata.​org). All those applications use Berkeley Software Distribution (BSD) type of license, which means they are free for distribution, modification, and private and commercial use and do not require any liabilities in return. All the data, both structured and unstructured, were firstly gathered in a Microsoft Excel (Microsoft office package, https://​products.​office.​com/​pl-pl/​excel) format with each patient bookmarked with a separate spreadsheet. From there it was imported into a Jupyter Notebook, where, using Python Pandas module, it was merged into one big dataset that used the time for its main index. It was then scrapped from duplications and empty rows, cleaned from unnecessary information and missing information was interpolated from nearby points. Those operations were necessary to create a data platform that was subsequently investigated by adding to it different set of constrains. Finally, visual analysis was made with the use of 2D and 3D plots.
Table 1
Demographic characteristics of the study group
Number of patients (n)
272
Age (years), mean ± SD
62.5 ± 12.4
Gender male, n (%)
203 (73.6)
Body surface area (m2), mean ± SD
1.95 ± 0.21
Body mass index, mean ± SD
28.38 ± 4.78
Risk factors, n (%)
 Coronary artery disease
190 (68.8)
 Hypertension
188 (68.1)
 Diabetes mellitus
79 (28.6)
 Hypercholesterolemia
59 (21.4)
 COPD
12 (4.3)
 ESRD
3 (1.1)
Type of surgery, n (%)
 CABG
133 (48,9)
 Other single procedure
95 (34,9)
 Double procedure
43 (15,8)
 Triple procedure
1 (0.4)
CABG Coronary bypass grafting, COPD Chronic obstructive pulmonary disease, ESRD End stage renal disease

Results

A total of 272 (mean age 62.5 ± 12.4, 74% male) cardiac surgery patients were included in this study. Nearly half of them (49.5%) underwent isolated CABG procedure, whereas 34.4% underwent another single procedure. A double procedure was conducted on 15.6% of patients. One patient underwent a triple procedure. Demographic findings of the study population are presented in Table 1. The formation of heterogeneous information derived from patient baseline characteristics along with operative details and the results of in-line real-time CPB monitoring and pump flow rate measurements created a common platform for coherent multi-modal data processing. As the methodology of Data Science enables the analysis of various types of data, the rejection of erroneous readings and the use of regression methods, we employed it to identify and analyse diagnostic and therapeutic features for the ECC. It was ensured that the database was cleared from any duplications and empty rows. The first visual analysis of the gathered data shows haemoglobin concentration and cardiac index (CI) value on x and y-axis respectively (Fig. 1). Oxygen delivery (DO2i) was illustrated in colour, where darker shades correspond with lower values. The image reveals a predictable pattern in whichthe DO2i level goes up with both Hb and CI. It also reveals that most of the measurements were taken for CI set between 1,3–2,8 L/min/m2 and Hb values between 9 and 12 g/dL. The database contained a moderate amount of DO2i values lower than 280 mL/min/ m2. In the majority of cases they resulted from short-term blood flow reductions from the CPB related to cardiac surgical procedures. Continuing data analysis, we carefully selected data for which the minimum value of DO2i was at least 280 mL/min/m2 and SvO2 was above 68%. Additionally, the impact of outlier points that go out of the pattern at random due to various measurement uncertainties was reduced by shortening the database by those rows where CI values had less than 1 hundred corresponding Hb measurements. Those new constraints left a strong visible pattern in the data (Fig. 2). The arch-shaped cut on the lower part of the scattered data in Fig. 2 corresponds to the relationship between CI and Hb for our limit DO2 value. To study the relation, we extracted the data for three different values (280 ml/min/m2, 330 ml/min/m2and380ml/min/m2) of oxygen delivery (DO2i), which were subsequently described with weighted linear regression of second order (Fig. 3). Each set of those lines shows a descending function of CI in Hb concentration for the set DO2i.

Discussion

Recently accumulating evidence has suggested that the trends in current perfusion practice need to be improved as we experience tremendous technological improvement every day. The discussed new GDP concept provides an ideal opportunity to apply treatment which is tailored to the individual patient’s needs and, therefore, aims to diminish the risk of complications throughout the entire surgical procedure. Consequently, the emerging concept jeopardizes the current widely accepted CPB strategies of organ perfusion based on a constant pump flow rate and the ubiquitous indicators of tissue perfusion, such as lactate concentration and urine output, with lactates representing effective tissue perfusion and metabolism balance, and urine output being a vital indicator of renal perfusion. The main goal of GDP is to optimize tissue oxygen delivery and extraction. Interestingly, adequate perfusion represented by the flow rate is a crucial component of DO2.
In current clinical practice, the haemodynamic values used by perfusionists are based solely on observational studies designed on the basis of the physiology of a healthy individual. For instance, the pump flow rate is the equivalent of the average calculated cardiac index (CI). However, one should raise a question whether the haemodynamic parameters observed in a healthy individual can be adapted during the ECC when the heart and pulmonary circulation are switched off from the bloodstream and the tangible pump flow rate reflects the unique physiology of cardiac output only to a small extent. The advancement in System M in-line non-invasive monitoring provides an opportunity to conduct real-time observation of flow rates, both venous and arterial saturation, haemoglobin level, the extent of carbon dioxide production and also calculate all exponents of oxygen transport. The aim of our study was to find the relationships between the set pump flow rates and the ultimate GDP conditions, such as DO2 > 280 mL/min/m2, SvO2 > 68% and the minimum MAP of 60 mmHg. Statistical analysis was performed with Data Science calculation tool, which is more frequently introduced as codes that can assess with high probability if, for instance, a skin mole will turn into cancer or classify genes responsible for leukaemia [12, 13]. In our study, we strived to present how the application of this technology can help to easily visualise the correlation between factors that would be incalculable elsewhere. Using the described tools, the pattern in the data that corresponds to the relationship between CI and Hb for the same DO2i value was derived (Fig. 3). Hence, to ensure a certain level of DO2 at MAP> 60 mmHg, haemoglobin value necessitates the adjustment of the appropriate pump flow rate. The graph illustrates that at Hg of 10 g%, the initial pump flow rate within the study population was set on 2.2 l/min/m2, while at Hg level of 8 g% the pump flow rate should be sustained on approximately 2.6 l/min/m2. The described relationship is part of the GDP concept, however, the perfusion pressure above 60 mmHg is an additional parameter that was analysed.

Conclusions

The presented observations reflect substantial mechanisms in the newly created haemodynamic patient – heart-lung machine model. Nevertheless, the depicted concept requires further observation. Appropriate models dedicated to higher perfusion pressures and different DO2 values should be evaluated as it would be extremely useful in managing patients concurrently affected by primary cerebral and visceral hypoperfusion in particular. The revealed relationship outlines basic values for the initial settings of the heart-lung machine to optimize perfusion during the ECC. Moreover, perfusion strategy should be individualized to match the patient’s unique physiology that changes over time.

Acknowledgements

None.
Not applicable.
N/A.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Murphy GS, Hessel EA, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg. 2009;108(5):1394–417.CrossRef Murphy GS, Hessel EA, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg. 2009;108(5):1394–417.CrossRef
2.
Zurück zum Zitat Shaefi S, Mittel A, Klick J, Evans A, Ivascu NS, Gutsche J, Augoustides JGT. Vasoplegia after cardiovascular procedures—pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018;32(2):1013–22.CrossRef Shaefi S, Mittel A, Klick J, Evans A, Ivascu NS, Gutsche J, Augoustides JGT. Vasoplegia after cardiovascular procedures—pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018;32(2):1013–22.CrossRef
3.
Zurück zum Zitat Clowes GHA, Neville WE, Sabga G, Shiboh Y. The relationship of oxygen consumption, perfusion rate, and temperatue to acidosis associated with cardiopulmonary bypass. Surgery. 1958;44:220–3.PubMed Clowes GHA, Neville WE, Sabga G, Shiboh Y. The relationship of oxygen consumption, perfusion rate, and temperatue to acidosis associated with cardiopulmonary bypass. Surgery. 1958;44:220–3.PubMed
4.
Zurück zum Zitat Barry AE, Chaney MA, London MJ. Anesthetic management during cardiopulmonary bypass: a systematic review. Anesth Analg. 2015;120(4):749–69.CrossRef Barry AE, Chaney MA, London MJ. Anesthetic management during cardiopulmonary bypass: a systematic review. Anesth Analg. 2015;120(4):749–69.CrossRef
5.
Zurück zum Zitat Ranucci M, Johnson I, Willcox T, Baker RA, Boer C, Baumann A, et al. Goal-directed perfusion to reduce acute kidney injury: a randomized trial. J Thorac Cardiovasc Surg. 2018;156(5):1918–27.CrossRef Ranucci M, Johnson I, Willcox T, Baker RA, Boer C, Baumann A, et al. Goal-directed perfusion to reduce acute kidney injury: a randomized trial. J Thorac Cardiovasc Surg. 2018;156(5):1918–27.CrossRef
6.
Zurück zum Zitat Awad H, Essandoh M. Goal-directed oxygen delivery during cardiopulmonary bypass: can this perfusion strategy improve biochemical and CIinical neurologic outcomes? J Cardiothorac Vasc Anesth. 2018;32(6):2493–4.CrossRef Awad H, Essandoh M. Goal-directed oxygen delivery during cardiopulmonary bypass: can this perfusion strategy improve biochemical and CIinical neurologic outcomes? J Cardiothorac Vasc Anesth. 2018;32(6):2493–4.CrossRef
7.
8.
Zurück zum Zitat Gill J, Prasad V. Improving observational studies in the era of big data. Lancet. 2018;392(10149):716–7.CrossRef Gill J, Prasad V. Improving observational studies in the era of big data. Lancet. 2018;392(10149):716–7.CrossRef
9.
Zurück zum Zitat Kong HJ. Managing unstructured big data in healthcare system. Heal Inf Res. 2019;25(1):1–2.CrossRef Kong HJ. Managing unstructured big data in healthcare system. Heal Inf Res. 2019;25(1):1–2.CrossRef
10.
Zurück zum Zitat Orphanidou C. A review of big data applications of physiological signal data. Biophys Rev. 2019;11:83.CrossRef Orphanidou C. A review of big data applications of physiological signal data. Biophys Rev. 2019;11:83.CrossRef
11.
Zurück zum Zitat Chung NC, Ping P, Mirza B, Wang W, Wang J, Choi H. Machine learning and integrative analysis of biomedical big data. Genes. 2019;10:87.CrossRef Chung NC, Ping P, Mirza B, Wang W, Wang J, Choi H. Machine learning and integrative analysis of biomedical big data. Genes. 2019;10:87.CrossRef
12.
Zurück zum Zitat Walker BN, et al. Dermoscopy diagnosis of cancerous lesions utilizing dual deep learning algorithms via visual and audio (sonification) outputs: laboratory and prospective observational studies. EBioMedicine. 2019;40:176–83.CrossRef Walker BN, et al. Dermoscopy diagnosis of cancerous lesions utilizing dual deep learning algorithms via visual and audio (sonification) outputs: laboratory and prospective observational studies. EBioMedicine. 2019;40:176–83.CrossRef
13.
Zurück zum Zitat Castillo D, et al. Leukemia multiclass assessment and classification from microarray and RNA-seq technologies integration at gene expression level. PLoS One. 2019;14(2):e0212127.CrossRef Castillo D, et al. Leukemia multiclass assessment and classification from microarray and RNA-seq technologies integration at gene expression level. PLoS One. 2019;14(2):e0212127.CrossRef
Metadaten
Titel
The use of data science to analyse physiology of oxygen delivery in the extracorporeal circulation
verfasst von
Marceli Lukaszewski
Rafal Lukaszewski
Kinga Kosiorowska
Marek Jasinski
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2019
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-01301-6

Weitere Artikel der Ausgabe 1/2019

BMC Cardiovascular Disorders 1/2019 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.